Cytokinetics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Amgen USD 33.53B 140M 2024-12
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Cytokinetics USD 118K 0 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Exelixis USD 282K 4K 2025-01
Geron USD 606K 3K 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Intra Cellular Therapies USD 11K 0 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Ligand Pharmaceuticals USD 20K 1000 2024-12
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06



Cytokinetics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.